Austria ADHD (Attention Deficit Hyperactivity Disorder) Therapeutics Market

1. A sample report on Austria ADHD (Attention Deficit Hyperactivity Disorder) Therapeutics Market Analysis

2. This report presents a strategic analysis of the Austria ADHD (Attention Deficit Hyperactivity Disorder) Therapeutics Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc. This is one of the most comprehensive reports about the Austria ADHD (Attention Deficit Hyperactivity Disorder) Therapeutics Market, and offers unmatched value, accuracy, and expert insights.

3. Report Scope Report Attribute Details Number of Pages 70-80 Base Year for Estimation 2023 Forecast Period 2024-2030 Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement Scenario Report Coverage Quantitative Units Revenue in USD Million/Bn (Mn/Bn) Research Approach Secondary Research (60%), Primary Research (40%) Click on the icon to know the detailed methodology 3 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

4. Table of Content CONTENT PG. NO. 07-16 1. Austria ADHD Therapeutics Market Overview 1.1. ADHD Overview 1.2. ADHD Scenario in the World 1.3. Austria Overview 1.4. Economic Overview: Austria 1.5. Statistics at a Glance 1.6. Therapeutics Market in Austria 1.7. Healthcare Scenario in Austria 1.8. Budget of Austria government for Public Insurance 17-18 2. Overview 2.1. Types of ADHD 19-25 3. Market Size and Forecasting 3.1. Market Size and Forecasts (Excel and Methodology) 4 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

5. Table of Content CONTENT PG. NO. 3.2. Market Segmentation 3.2.1. Drug 3.2.2. Drug Type 3.2.3. Demographic 3.2.4. Distribution Channel 26-31 4. Market Dynamics 4.1. Market Growth Drivers 4.2. Market Restraints 32-40 5. Competitive Landscape 5.1. Major Market Share 5.2. Key Players in Austria ADHD Therapeutics Market 5.2.1. Johnson & Johnson 5.2.2. Pfizer 5 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

6. Table of Content CONTENT PG. NO. 5.2.3. Novartis 5.2.4. Takeda 5.2.5. Eli Lilly 5.2.6. Teva 5.2.7. GSK 5.2.8. Janssen 5.2.9. Sanofi 5.2.10. UCB 6. Regulatory Landscape –Austria 6.1. Regulations in Austria 7. Methodology & Scope 6 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

7. Austria ADHD (Attention Deficit Hyperactivity Disorder) Therapeutics Market Analysis 1. Market Overview

8. 1.1 ADHD (Attention Deficit Hyperactivity Disorder) Overview ADHD, or Attention-Deficit/Hyperactivity Disorder, is a neurodevelopmental condition marked by enduring patterns of inattention, hyperactivity, and impulsivity, leading to notable effects on daily functioning and developmental processes with symptoms typically manifesting during childhood and can persist into adolescence and adulthood ▪ Treatment approaches commonly include behavioral therapy, psychoeducation, and, in certain cases, the use of medications such as stimulants and non-stimulants to address symptoms and improve overall functioning ▪ ADHD can be primarily categorized into three subtypes which include: Inattentive and Distractable type: Characterized by difficulties in maintaining focus, organizing tasks, and completing activities ▪ Hyperactive and Impulsive type: Characterized by heightened physical activity, restlessness, impulsive actions, and challenges in waiting ▪ Combines presentation: Characterized by both distractibility and impulsiveness in behavior ▪

9. 1.2 ADHD Scenario in the World Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic ▪ 8% Individuals globally are affected by ADHD 32% Of childhood ADHD is treated with both medication and behavioral treatment In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 129 Mn Of adults and children in the age group of 5-19 years have ADHD worldwide 75% Of ADHD cases remain undiagnosed globally Illustrative Illustrative 9 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

10. 1.2 ADHD Scenario in the World Regional Analysis ➢ Africa: $_ _ ➢ APAC: $_ _ ➢ Europe: $_ _ ➢ LATAM: $_ _ Austria Market ~$xx Bn Market ➢ Middle East: $_ _ ➢ North America: $_ _ Illustrative Illustrative 10 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

11. 1.3 Austria Overview Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the topic, which includes the prevalence of the disease, the application of medical devices, new technology, and other details related to the topic ▪ $471 Bn Is the Gross Domestic Product in Austria in 2022 8.9 Mn Population of Austria in 2023 In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 43.1 Years Is the median age in Austria in 2023 12.17% Of Austria ’s GDP is spent on health in 2022 Illustrative Illustrative 11 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

12. 1.4 Economic Overview: Austria Population of Austria, (in $ Mn) GDP of Austria, (in $ Bn) XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX XX 2016 2017 2018 2019 2020 2021 2022 2023 2016 2017 2018 2019 2020 2021 2022 2023 Population Split (2023) In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, healthcare expenditure and other details related to the topic ▪ By Gender By Age Group XX In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ XX XX 0-14 15-24 25-54 XX Female, XX Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Male, XX ▪ 55-64 65+ XX Illustrative Illustrative 12 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

13. 1.5 Statistics at a Glance: ADHD in Austria In this section you will get an understanding of the topic, which includes the prevalence of the disease, population estimates of the disease and other details related to the topic ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ 19/100,000 Psychiatrists are available as of 2017 in Austria 3.3 Mn Children suffer from ADHD in European Union In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 1.2%-7.3% Is the adult prevalence of ADHD in Austria 1,147/100,000 Prevalent cases of ADHD in Austria Illustrative Illustrative 13 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

14. 1.6 Pharmaceutical Market in Austria Austria Pharmaceutical Market Forecast, 2023-2030 (in $Bn) 2023 2024F 2025F 2026F 2027F 2028F 2029F 2030F Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In this section you will get an understanding of the overall Digital Health market in Austria , which includes the market size, current trends and other details related to the topic ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 14 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

15. 1.7 Healthcare Scenario in Austria Public Healthcare ▪ Operates a universal public healthcare system, offering quality care to all citizens ▪ Funded through mandatory social health insurance contributions from both employees and employers ▪ Covers essential healthcare, medications, specialist consultations, and dental care. Visiting doctors under this system typically requires presenting an e-card Private Healthcare ▪ Provides faster access to top doctors and amenities such as private hospital rooms ▪ While advantageous, it tends to be costly, particularly for older individuals ▪ Advantages include shorter wait times, broader networks of doctors and private hospitals Insurance Government Programs ▪ Austrian Health Promotion Fund: spearheads national health promotion and prevention initiatives, supported by federal government funding ▪ Austrian Health Targets: represent 10 overarching health policy objectives jointly devised by the government and stakeholders. These goals focus on enhancing public health and narrowing health disparities Health insurance is compulsory for all Austrian residents, who can choose between public or private options ▪ Public insurance is obligatory for employees and extends coverage to their family members ▪ Unemployed and low-income individuals are covered by public insurance without any monthly fee ▪ Illustrative Illustrative 15 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

16. 1.8 Budget of Austria Government for Public Insurance Proposed Budget By Category 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2022-31 Outlays $769 $709 $766 $841 $840 $947 $1,014 $1,085 $1,227 $1,178 $1,325 $1,412 $10,633 In Bns Of Dollars Medicare 3.7% 3.2% 3.3% 3.4% 3.3% 3.6% 3.7% 3.8% 4.1% 3.8% 4.1% 4.2% 3.7% As % Of GDP National Health Expenditures (NHE) grew 2.7% to $4.3 Tn in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP) ▪ Medicare spending grew 8.4% to $900.8 Bn in 2021, or 21% of total NHE ▪ Private health insurance spending grew 5.8% to $1,211.4 Bn in 2021, or 28% of total NHE ▪ Out of pocket spending grew 10.4% to $433.2 Bn in 2021, or 10% of total NHE ▪ Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 Bn, or 14% of total NHE ▪ Hospital expenditures grew 4.4% to $1,323.9 Bn in 2021, slower than the 6.2% growth in 2020 ▪ Physician and clinical services expenditures grew 5.6% to $864.6 Bn in 2021, slower growth than the 6.6% in 2020 ▪ Prescription drug spending increased 7.8% to $378.0 Bn in 2021, faster than the 3.7% growth in 2020 ▪ Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7% ▪ Illustrative Illustrative 16 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

17. Austria ADHD (Attention Deficit Hyperactivity Disorder) Therapeutics Market Analysis 2. Overview

18. 2.1 Types of ADHD ADHD is classified into three types: inattentive, hyperactive/impulsive, and combined, where in combined type individuals exhibit symptoms of both inattention and hyperactivity/impulsivity, varying in severity Inattentive Type Impulsive Type Characterized by challenges in staying on task, focusing, and organization Marked by excessive movement, fidgeting, and talkativeness (hyperactivity), along with impulsive decision-making Diagnosis requires frequent occurrence of six (or five for individuals aged 17 or older) of the following symptoms: Diagnosis requires frequent occurrence of six (or five for individuals aged 17 or older) of the following symptoms: Inattentiveness to details or making careless mistakes. Fidgeting or tapping hands or feet ▪ ▪ Difficulty staying focused during tasks or activities. Inability to stay seated ▪ ▪ Appears to not listen when spoken to. Running or climbing in inappropriate settings ▪ ▪ Lack of follow-through on instructions or tasks. Difficulty engaging in quiet activities ▪ ▪ Problems organizing tasks and work Constantly active, as if driven by a motor ▪ ▪ Avoidance of tasks requiring sustained mental effort Excessive talking ▪ ▪ Frequently loses necessary items Blurting out answers before questions are finished ▪ ▪ Easily distracted Difficulty waiting for one's turn ▪ ▪ Forgetting daily tasks Interrupting or intruding on others ▪ ▪ 18 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

19. Austria ADHD (Attention Deficit Hyperactivity Disorder) Therapeutics Market Analysis 3. Market Size and Forecasting

20. 3.1 Market Size and Forecasts (Excel and Methodology) Austria ADHD (Attention Deficit Hyperactivity Disorder) Therapeutics Market Forecast, 2023-2030 In this section you will get an understanding of the topic, which includes anticipated growth of the ADHD drugs market in the forecasted period and the growth potential of Austria market as compared to global market size ▪ XX Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ 2023 2024F 2025F 2026F 2027F 2028F 2029F 2030F In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ 2023 2024 2025 2026 2027 2028 2029 2030 Major Markets Patient ($Mn) 2.74 2.82 2.90 2.94 2.98 3.02 3.07 3.12 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Austria Patient Size ($Bn) 0.51 0.61 0.68 0.69 0.70 0.71 0.72 0.73 % of Patients 18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45% Global Market Size ($Bn) 3,620 3,780 3,950 4,128 4,314 4,508 4,711 4,937 Click on the icon to know the calculations and assumption Austria Market Size ($Bn) 61 74 84 87 91 95 99 106 Illustrative Illustrative 20 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

21. 3.2 Snapshot of Austria ADHD Therapeutics Market Segmentation Drug Drug Type Demographics Distribution Channel Amphetamine Stimulant Adult (18 and above) Online Pharmacies Methylphenidate Non-stimulant Children Retail Pharmacies Lisdexamfetamine Dexmethylphenidate Clonidine Guanfacine In this section you will get an understanding of the segmentations which will cover the Austria ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Illustrative Illustrative 21 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

22. 3.2.1 Market Segmentation: By Drug In this section you will get an understanding of the topic, which includes the segmentation by drugs of the Austria ADHD therapeutics market along wit their market share ▪ Austria ADHD (Attention Deficit Hyperactivity Disorder) Therapeutics Market Share, By Drug (2023) Dexamethylpheni date Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Methylphenadite Amphetamine In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Guanfacine Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Lisdexamfetamine Clonidine Illustrative Illustrative 22 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

23. 3.2.2 Market Segmentation: By Drug Type In this section you will get an understanding of the topic, which includes the segmentation by drug type of the Austria ADHD therapeutics market along wit their market share ▪ Austria ADHD (Attention Deficit Hyperactivity Disorder) Therapeutics Market Share, By Drug Type (2023) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Stimulant In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Non-stimulant Illustrative Illustrative 23 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

24. 3.2.3 Market Segmentation: By Demographics In this section you will get an understanding of the topic, which includes the segmentation by demographics of the Austria ADHD therapeutics market along wit their market share ▪ Austria ADHD (Attention Deficit Hyperactivity Disorder) Therapeutics Market Share, By Demographics (2023) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Adult In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Children Illustrative Illustrative 24 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

25. 3.2.4 Market Segmentation: By Distribution Channel In this section you will get an understanding of the topic, which includes the segmentation by distribution channel of the Austria ADHD therapeutics market along wit their market share ▪ Austria ADHD (Attention Deficit Hyperactivity Disorder) Therapeutics Market Share, By Distribution Channel (2023) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Retail Pharmacies In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Online Pharmcies Illustrative Illustrative 25 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

26. Austria ADHD (Attention Deficit Hyperactivity Disorder) Therapeutics Market Analysis 4. Market Dynamics

27. 4. Snapshot Of Market Growth Drivers And Restraints 4.1.1 4.1.2 4.1.3 Initiatives for increasing awareness regarding ADHD in Austria Rise in per capita healthcare spending by Austrian government High prevalence of ADHD in Austria 4.2.1 4.2.2 High cost of treatment Multiple side effects for ADHD therapeutics Illustrative Illustrative 27 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

28. 4.1.1 Rise in per capita healthcare spending by Austrian government In 2021, per capita health expenditure, adjusted for purchasing power, rose to $5,055 making it the second highest in the EU after Germany and well above the EU average of $4,367 ▪ Per capita healthcare spending This increase in healthcare spending can serve as a market driver for ADHD therapeutics ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2010 2022 2030 Illustrative Illustrative 28 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

29. 4.1.2 High prevalence of ADHD in Austria In Austria, the prevalence of ADHD stands at 1,147 cases per 100,000 population, surpassing that of most European countries ▪ Prevalence of ADHD in Austria This high prevalence rate is likely to boost the demand for ADHD therapeutics in the market ▪ Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 2010 2022 2030 Illustrative Illustrative 29 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

30. 4.1.3 Initiatives for increasing awareness regarding ADHD in Austria Various organizations, including ADHD Europe and ADAPT, are striving to raise awareness about ADHD across Europe and Austria ▪ Initiative Description These initiatives are likely to stimulate growth in the ADHD therapeutics market by increasing demand and promoting better understanding and support for individuals with ADHD ▪ Dedicated to fighting the stigma, injustice, and intolerance that individuals with ADHD encounter in their daily lives ▪ ADHD Europe Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ It is a self-help association dedicated to supporting individuals with ADHD ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ They provide information about the condition, connect people to specialized support services like diagnostic and therapy centers, and regularly organize self-help meetings for various age groups and target audiences ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ ADAPT Illustrative Illustrative 30 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

31. 4.2 Market Restraints 4.2.2 High cost of treatment 4.2.1 Multiple side effects for ADHD therapeutics Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ ▪ In order to obtain access to all of the information that you are seeking, you will need to purchase the final report In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ ▪ Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ ▪ Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth. Illustrative Illustrative 31 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

32. Austria ADHD (Attention Deficit Hyperactivity Disorder) Therapeutics Market Analysis 5. Competitive Landscape

33. 5.2 Key Players in Austria ADHD Therapeutics Market Here is the list of top 10 companies which will cover in the final report ▪ 1 6 Johnson & Johnson Teva Pharmaceuticals Each company will have slides for ▪ Overview Key details Offerings Name of products Recent activities/ Press Coverage Distribution and Vendor Partners Mergers, Acquisitions and Collaboration Financials If there are specific companies that you would like to be included in the report, please let us know via email In order to obtain access to all of the information that you are seeking, you will need to purchase the final report o o 2 7 Pfizer GSK o o o o o 3 8 Novartis Janssen o ▪ 4 9 Takeda Pharmaceutical Sanofi ▪ 10 5 Eli Lilly UCB Illustrative Illustrative 33 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

34. 5.2.1 Johnson & Johnson Offerings Founded in: 1886 ▪ Johnson & Johnson is a multinational healthcare company, with a varied portfolio that encompasses pharmaceuticals, medical devices, and consumer health products ▪ It aims to addresses complex diseases through its pharmaceutical division, Janssen which is dedicated to developing cutting-edge treatments for areas like oncology, immunology, and others ▪ It functions in more than 60 countries while being a leader in advancing human health and making a global impact ➢ Neuroscience HQ: New Jersey, United States ➢ Immunology Type: Private Revenue: $52.60 Bn (Global) ➢ Oncology Website: www.jnj.com ➢ Cardiovascular Recent Activity / Press Coverage ▪ January 08, 2024 — It has entered a definitive agreement to purchase Ambrx Biopharma, Inc., a clinical-stage biopharmaceutical company utilizing a proprietary synthetic biology technology platform for the creation and advancement of next-generation antibody drug conjugates (ADCs). This acquisition will be an all-cash merger transaction, totaling approximately $2.0 Bn in equity value, or $1.9 Bn after accounting for estimated acquired cash ▪ July 24, 2023— Split-off of J&J's consumer-health business provides the company with a substantial cash infusion, amounting to Bns, to allocate capital towards its remaining businesses. The $40 Bn gained from this split will be redirected to support the expansion of the pharmaceutical and medical technology sectors ▪ November 1, 2022— Johnson & Johnson has consented to acquire the cardiovascular technology group Abiomed for a total of $16.6 Bn, which includes the assumption of debt. The agreed-upon purchase price is $380 for each outstanding share of Abiomed, reflecting Johnson & Johnson's strategic shift towards prioritizing drugs and medical devices 34 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

35. 5.2.1 Johnson & Johnson (Continued) Latest Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers It split-off around 80% of the shares of Kenvue Inc, which is the consumer health business Goal of the split is to realign the business and simplify its operations By eliminating the consumer division, Johnson & Johnson intends to allocate more resources to the development of pharmaceuticals and medical devices, which collectively generated approximately $80 Bn in revenue for the company ▪ ▪ July, 2023 Spilt-Off $40 Bn ▪ Illustrative Illustrative 35 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

36. 5.2.1 Johnson & Johnson (Continued) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Revenues ($Bn), 2020-2030 In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Breakdown of Net Revenue by Segment, 2023 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 1 2 3 4 Illustrative Illustrative 36 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

37. 5.2.2 Company 2 Solutions offered by Company Founded in: HQ: Type: Revenue: Website: Drugs for Telemedicine Recent Activity / Press Coverage Drugs Indications 37 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

38. 5.2.2 Company 2 (Continued) Partnerships Ecosystem Major Distribution Partners Major Vendor Partners 38 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

39. 5.2.2 Company 2 (Continued) Latest Deals - Mergers and Acquisitions Amount / Duration Company Name Type Year Key Pointers 39 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

40. 5.2.2 Company 2 (Continued) Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report ▪ Revenues ($Bn), 2020-2030 xx xx xx In this section you will the understating of financial overview of the company, which includes revenue forecasting, segment revenue and other key details as per availability ▪ 2020 2021 2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2030F In order to obtain access to all of the information that you are seeking, you will need to purchase the final report ▪ Breakdown of Net Revenue by Segment, 2022 Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ 1 2 3 4 40 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

41. Austria ADHD (Attention Deficit Hyperactivity Disorder) Therapeutics Market Analysis 6. Reimbursement Scenario

42. 6.1 Reimbursement Regulation in Austria Regulatory Authorities With Jurisdiction Over Drugs And Biologicals In Austria In Austria, marketing authorizations fall under the jurisdiction of the Austrian Medicines Act (AMG), while pricing and reimbursement are managed by the Austrian General Social Insurance Law (ASVG) ▪ Additionally, the ASVG oversees the Reimbursement Code (EKO), which comprises a list of medicines approved for reimbursement ▪ Key regulatory bodies managing pharmaceuticals in Austria are: ▪ The Austrian Agency for Health and Food Safety (AGES): Evaluates marketing authorization applications, decides on prescription status, and supervises pharmacovigilance for medications ▪ The Austrian Federal Agency for Safety in Health Care (BASG): Issues marketing authorizations for medicinal products, unless authorized at the EU level ▪ Enforces laws concerning medicine advertising ▪ The Federation of Austrian Social Insurance Institutions: Coordinates 21 social security institutions offering health insurance ▪ It establishes the Reimbursement Code, which outlines medicines eligible for reimbursement ▪ Illustrative Illustrative 42 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

43. 6.1 Reimbursement Regulation in Austria (Continued) Coverage Penetration (% Total Population) Source of Funding Spend on Healthcare (%of Current Health Expenditure) 100% 100% 100% 100% 100% 44.0% Government Expenditure xx 46.0% xx 47.7% xx xx xx 51.0% 51.8% Public Healthcare Coverage Private Health Insurance Out of Pocket 38.9% 37.1% 35.6% 31.5% 32.5% Private Coverage Other NA NA 2019 2020 2021 2022 2023 2017 2018 2019 2020 2021 2022 2023  Public healthcare coverage is provided by the government and includes programs like Medicare and Medicaid  Medicare is a federal program that provides healthcare coverage to individuals who are 65 years of age or older, as well as certain younger people with disabilities 6.3% 4.08% 5.1% 3.8% 2.2% 2.4% 3.6% GDP Growth (yoy) 14.7% 11.3% 15.5% 7.5% 4.2% NA NA HC Spend Growth (yoy) Reimbursement Market Trends ▪ Shift towards value-based care has been a significant trend in Austria healthcare system, with payers and providers increasingly focused on improving patient outcomes and reducing costs ▪ This has led to the development of alternative payment models such as accountable care organizations (ACOs) and bundled payment arrangements, which incentivize providers to deliver high-quality, cost-effective care Illustrative Illustrative 43 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

44. 6.2 Reimbursement Process The reimbursement process in Austria healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process: Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient ▪ Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service provided ▪ Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential errors or fraud ▪ Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service provided, based on the negotiated payment rates or fee schedule ▪ Patient Responsibility: Depending on the patient's insurance coverage, they may be responsible for paying a portion of the cost of the service, such as deductibles, co-payments, or co-insurance In order to obtain access to all of the information that you are seeking, you will need to purchase the final report Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest ▪ Illustrative Illustrative 44 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

45. 6.3 Reimbursement Process (Continued) The reimbursement process in Austria healthcare system can be complex and can vary depending on the type of healthcare service, the healthcare provider, and the insurance coverage. Here are the general steps involved in the reimbursement process: MoH Service or Treatment Provided: The healthcare provider performs a service or treatment for the patient ▪ Market Authorization Billing: The healthcare provider submits a claim to the insurance company or other payer, requesting reimbursement for the service provided ▪ Private Payers Public Payers Adjudication: The insurance company or other payer reviews the claim to determine whether it meets the criteria for reimbursement. This can involve verifying the patient's eligibility, reviewing the treatment provided, and checking for any potential errors or fraud ▪ Health Technology Assessment Payment: If the claim is approved, the insurance company or other payer reimburses the healthcare provider for the service provided, based on the negotiated payment rates or fee schedule ▪ 1 2 3 Coding Coverage Payment Coding depends on availability code while coverage and payment process decisions are made through an HTA. Illustrative Illustrative 45 A Sample Report on Austria ADHD Therapeutics Market Analysis I Confidential

46. A division of

47. Life-sciences Market Research Reports you can trust We maintain an extensive database comprising over 30,000 syndicated market research reports within the pharmaceuticals and healthcare sector, offering a global, regional, and country-level perspective. Our services also include the provision of customized research reports, meticulously tailored to align with your specific requirements. www.insights10.com www.insights10.com

48. Pharma (Diseases & Drugs) Digital Health Market Research Reports across various categories in healthcare OTC & Medical Devices Nutraceuticals At Insights10, our extensive report library spans a diverse range of categories within the field of life sciences. Clinical Trials Healthcare Services Rare Diseases www.insights10.com www.insights10.com

49. Global Coverage Europe • UK • Germany • France • Italy • Spain • Russia • Netherlands • Sweden • Romania • Switzerland • Poland • Austria • Ireland • Norway • Denmark • Belgium • Portugal • Ukraine • Bulgaria • Finland APAC • India • China • South Korea • Japan • Australia • Indonesia • Hong Kong • New Zealand • Austria • Singapore • Malaysia • Thailand • Vietnam North America • US • Canada Africa • Egypt • Kenya • South Africa • Algeria • Nigeria • Libya • Tanzania • Morocco Middle East • UAE • Saudi Arabia • Turkey • Lebanon • Kuwait • Qatar Latin America • Brazil • Argentina • Mexico • Ecuador • Venezuela • Senegal Click on the country to see the reports available

50. What do our reports cover? Market Overview Competitive Landscape 1 6 Growth Drivers & Growth Restraints 2 7 Policy & Regulatory Landscape Epidemiology & Disease type 3 8 Reimbursement Scenario Market Size & Forecast Recent Developments 4 9 Market Segmentation Factors Driving Future Growth 5 10